Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BAZAN, Viviana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.974
EU - Europa 13.660
AS - Asia 10.513
SA - Sud America 1.779
Continente sconosciuto - Info sul continente non disponibili 1.240
AF - Africa 307
OC - Oceania 53
Totale 54.526
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.331
SG - Singapore 3.926
RU - Federazione Russa 3.377
CN - Cina 2.658
IT - Italia 2.598
DE - Germania 1.899
FI - Finlandia 1.799
BR - Brasile 1.361
HK - Hong Kong 1.038
VN - Vietnam 913
UA - Ucraina 735
GB - Regno Unito 696
PL - Polonia 588
FR - Francia 493
IE - Irlanda 390
JP - Giappone 379
SE - Svezia 330
CA - Canada 309
IN - India 268
KR - Corea 243
BD - Bangladesh 242
NL - Olanda 153
TR - Turchia 128
BE - Belgio 125
IQ - Iraq 125
MX - Messico 123
AR - Argentina 116
RO - Romania 111
AT - Austria 90
ES - Italia 80
EC - Ecuador 72
CO - Colombia 69
ZA - Sudafrica 69
IR - Iran 66
PK - Pakistan 64
VE - Venezuela 63
ID - Indonesia 55
CI - Costa d'Avorio 49
AU - Australia 48
CR - Costa Rica 48
MA - Marocco 46
MY - Malesia 46
PH - Filippine 40
UZ - Uzbekistan 39
JM - Giamaica 38
CL - Cile 29
CZ - Repubblica Ceca 29
KE - Kenya 29
TN - Tunisia 29
AE - Emirati Arabi Uniti 28
SA - Arabia Saudita 27
EG - Egitto 25
NP - Nepal 25
CH - Svizzera 24
LB - Libano 22
HN - Honduras 21
LT - Lituania 21
PY - Paraguay 21
KZ - Kazakistan 20
DZ - Algeria 19
TW - Taiwan 19
UY - Uruguay 19
AZ - Azerbaigian 18
IL - Israele 18
NI - Nicaragua 18
TH - Thailandia 18
TT - Trinidad e Tobago 17
PT - Portogallo 16
DO - Repubblica Dominicana 15
PE - Perù 15
BG - Bulgaria 13
GR - Grecia 13
JO - Giordania 13
BO - Bolivia 11
EE - Estonia 11
EU - Europa 11
OM - Oman 11
PA - Panama 11
AL - Albania 10
GT - Guatemala 10
KG - Kirghizistan 10
DK - Danimarca 9
GE - Georgia 9
MD - Moldavia 8
SV - El Salvador 8
HU - Ungheria 7
PR - Porto Rico 7
PS - Palestinian Territory 7
BY - Bielorussia 6
MM - Myanmar 6
QA - Qatar 6
UG - Uganda 6
LV - Lettonia 5
NG - Nigeria 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
CY - Cipro 4
ET - Etiopia 4
GA - Gabon 4
Totale 53.217
Salva come PNG Salva come JPEG
Città #
Ashburn 3.268
Singapore 2.491
Fairfield 2.431
San Jose 2.018
Chandler 1.377
Woodbridge 1.349
Houston 1.148
Wilmington 1.103
Ann Arbor 1.035
Hong Kong 992
Seattle 973
Cambridge 789
Palermo 636
Moscow 633
Council Bluffs 557
Zgierz 489
Los Angeles 427
New York 414
Beijing 413
Santa Clara 409
Jacksonville 379
Dublin 378
Dallas 370
The Dalles 369
Tokyo 354
Helsinki 339
Medford 333
Ho Chi Minh City 301
Frankfurt am Main 278
Des Moines 258
Boardman 254
Nanjing 252
Lauterbourg 235
Chicago 234
Hanoi 218
Hefei 218
Princeton 214
Altamura 205
Rome 197
Lawrence 174
San Diego 174
Munich 155
São Paulo 146
Buffalo 130
Milan 130
Phoenix 128
Brussels 123
Dearborn 121
London 114
Tulsa 112
Ludwigshafen am Rhein 104
Orem 103
Jinan 83
Seoul 83
Atlanta 80
Shenyang 80
Warsaw 78
Nuremberg 73
Toronto 72
Brooklyn 70
Seongnam 70
Denver 69
Tianjin 68
Montreal 67
Nanchang 65
Venice 63
Kitzingen 61
Hebei 60
Guangzhou 59
Changsha 58
Bremen 55
Columbus 55
Kumar 55
Amsterdam 51
Chennai 51
Abidjan 49
Stockholm 48
Poplar 46
Jiaxing 44
Johannesburg 44
Rio de Janeiro 43
Boston 41
Baghdad 40
Da Nang 40
Springfield 39
San José 38
Tehran 38
Falls Church 36
Ningbo 36
San Francisco 35
Verona 35
Brasília 34
Haiphong 34
Izmir 34
Saint Petersburg 34
San Mateo 34
Hangzhou 32
Panama City 32
Philadelphia 32
Shanghai 32
Totale 32.528
Salva come PNG Salva come JPEG
Nome #
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 444
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment 392
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 377
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 371
EGFR inhibition in NSCLC: New findings…. and opened questions? 358
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 355
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 355
Male breast cancer. 354
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 351
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 348
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 344
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 341
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 338
Dietary restriction: could it be considered as speed bump on tumor progression road? 337
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 326
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 325
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 325
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 323
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 322
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 320
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 317
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 314
Anti-endothelin drugs in solid tumors 311
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 311
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 310
A headlight on liquid biopsies: a challenging tool for breast cancer management 309
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. 308
Breast cancer genome-wide association studies: there is strength in numbers 308
Founder mutations in BRCA1 and BRCA2 genes 307
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 306
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 302
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 301
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 298
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 298
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 294
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 293
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 293
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 290
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 290
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 289
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 287
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. 285
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 283
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 282
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 282
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients 282
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 280
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 280
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 279
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 278
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 278
Apoptosis: a relevant tool for anticancer therapy. 278
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 278
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. 278
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 277
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 277
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 277
Monoclonal antibodies in gastrointestinal cancers 273
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 272
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. 271
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations 271
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. 269
Ductal lavage: a way of carefully tracing the breast-secreting duct 269
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 269
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 267
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. 266
Nintedanib in NSCLC: Evidence to date and place in therapy 264
P16 ink4A, p53 alterations and S phase fraction are predictive of clinical outcome in laryngeal squamous cell carcinoma. 262
The role of Aurora-A inhibitors in cancer therapy. 262
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors 260
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 259
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 258
Laser Pressure Catapulting (LPC): Optimization LPC-System and Genotyping of Colorectal Carcinomas 257
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer 257
A missense mutation associated to early onset breast cancer in a sicilian woman. 256
A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation? 255
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. 253
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 253
VUS variants in BRCA genes of hereditary breast/ovarian cancer 252
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 251
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 251
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. 250
miR-20b Modulates VEGF Expression by Targeting HIF-1a and STAT3 in MCF-7 Breast Cancer Cells 250
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 249
Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. 249
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. 249
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 248
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma 248
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 248
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) 246
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. 246
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 244
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy 243
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 243
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 243
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) 241
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 241
TP53 mutations and microsatellite instability are prognostic factors in gastric cancer? 241
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 240
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. 237
Totale 28.749
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.637
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.201 0 0 84 126 157 121 200 144 287 372 257 453
2022/20233.910 426 749 86 468 429 583 216 283 410 30 171 59
2023/20242.018 84 241 139 157 127 405 230 241 21 71 23 279
2024/20255.922 103 356 383 434 261 294 622 559 357 733 753 1.067
2025/202619.491 1.645 625 1.222 1.575 1.902 2.886 2.541 1.947 1.399 2.369 646 734
2026/20273.857 877 623 2.357 0 0 0 0 0 0 0 0 0
Totale 54.526